General Information of the Compound
Compound ID |
CP0434705
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(pyridin-4-yl)piperazine
Show/Hide
|
||||||||||||||||||
Synonyms |
(4-pyridyl)piperazine
1-(4-Pyridyl)piperazine
1-(4-pyridinyl)piperazine
1-(4-pyridyl) piperazine
1-(4-pyridyl)-piperazine
1-(pyridin-4-yl)piperazine
1-Pyridin-4-yl-piperazine
1-[4-pyridyl]piperazine
1-pyridin-4-ylpiperazine
1008-91-9
4-(1-PIPERAZINYL)PYRIDINE
4-(1-piperazino)pyridine
4-Piperazinopyridine
4-pyridyl piperazine
4-pyridylpiperazine
AC1Q4WUQ
CHEMBL339069
EINECS 213-764-7
MFCD00040745
N-(4-Pyridyl)piperazine
PIPERAZINE, 1-(4-PYRIDINYL)-
PubChem22899
l-(4-pyridyl)piperazine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C9H13N3
|
||||||||||||||||||
Molecular Weight |
163.224
|
||||||||||||||||||
Canonical SMILES |
C1CN(CCN1)c1ccncc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C9H13N3/c1-3-10-4-2-9(1)12-7-5-11-6-8-12/h1-4,11H,5-8H2
Show/Hide
|
||||||||||||||||||
InChIKey |
OQZBAQXTXNIPRA-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
1008-91-9
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01943, Phospholipase D1
Clinical Information about the Compound